Aurinia Pharmaceuticals Inc (AUPH)

[moosedogger]

Yesterday's news seems like a pretty big deal:

Lupkynis treatment can improve kidney response regardless of disease progression at diagnosis.

Lupkynis Shows Further Efficacy as Treatment for Lupus Nephritis Regardless of Disease Stage

https://www.lupus.org/news/lupkynis-shows-further-efficacy-as-treatment-for-lupus-nephritis-regardless-of-disease-stage?utm_source=TW&utm_medium=social


H.C. Wainwright & Co. continues to like it (from twitter):

Tom Silver
@TomSilver39
HCW:” $AUPH LUPKYNIS Improves Renal Response in LN Patients of Various Disease States in Post-hoc Analysis; Affirm Buy, TP=$35.”